Gianluca Polvani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Gianluca Polvani has a total of 403 co-authors. Here are the top co-authors by number of shared publications:
Paolo Biglioli
38 shared publications- Marco Agrifoglio
Centro Cardiologico Monzino IRCCS
28 shared publications - Francesco Alamanni
Department of Cardiac Surgery, University of Milan, Milan, Italy
23 shared publications Luca Dainese
Cardiovascular Tissue Bank of Lombardia, Centro Cardiologico Monzino, Milan, Italy
19 shared publications- Giulio Pompilio
Università degli Studi di Milano 12 Department of Biomedical, Surgical and Dental Sciences Milan
16 shared publications Anna Guarino
Cardiovascular Tissue Bank of Milan, Centro Cardiologico Monzino IRCCS
15 shared publications
Latest Publications
- 1 September 2023
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 64 (6)
Does the AVNeo valve reduce wall stress on the aortic wall? A cardiac magnetic resonance analysis with 4D-flow for the evaluation of aortic valve replacement with the Ozaki technique
OBJECTIVES: Aortic valve neocuspidalization aims to replace the 3 aortic cusps with autologous pericardium pre-treated with glutaraldehyde, and it is a surgical alternative to the classical aortic valve replacement (AVR). Image-based patient-specific computational fluid dynamics allows the derivation of shear stress on the aortic wall [wall shear stress (WSS)]. Previous studies support a potential link between increased WSS and histological alterations of the aortic wall. The aim of this study is to compare the WSS of the ascending aorta in patients undergoing aortic valve neocuspidalization versus AVR with biological prostheses. METHODS: This is a prospective nonrandomized clinical trial. Each patient underwent a 4D-flow cardiac magnetic resonance scan after surgery, which informed patient-specific computational fluid dynamics models to evaluate WSS at the ascending aortic wall. The adjusted variables were calculated by summing the residuals obtained from a multivariate linear model (with ejection fraction and left ventricle outflow tract-aorta angle as covariates) to the mean of the variables. RESULTS: Ten patients treated with aortic valve neocuspidalization were enrolled and compared with 10 AVR patients. The aortic valve neocuspidalization group showed a significantly lower WSS in the outer curvature segments of the proximal and distal ascending aorta as compared to AVR patients (P = 0.0179 and 0.0412, respectively). WSS levels remained significantly lower along the outer curvature of the proximal aorta in the aortic valve neocuspidalization population, even after adjusting the WSS for the ejection fraction and the left ventricle outflow tract-aorta angle [2.44 Pa (2.17–3.01) vs 1.94 Pa (1.72–2.01), P = 0.02]. CONCLUSIONS: Aortic valve neocuspidalization hemodynamical features are potentially associated with a lower WSS in the ascending aorta as compared to commercially available bioprosthetic valves.
- 1 September 2023
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 64 (6)
Does the AVNeo valve reduce wall stress on the aortic wall? A cardiac magnetic resonance analysis with 4D-flow for the evaluation of aortic valve replacement with the Ozaki technique
OBJECTIVES: Aortic valve neocuspidalization aims to replace the 3 aortic cusps with autologous pericardium pre-treated with glutaraldehyde, and it is a surgical alternative to the classical aortic valve replacement (AVR). Image-based patient-specific computational fluid dynamics allows the derivation of shear stress on the aortic wall [wall shear stress (WSS)]. Previous studies support a potential link between increased WSS and histological alterations of the aortic wall. The aim of this study is to compare the WSS of the ascending aorta in patients undergoing aortic valve neocuspidalization versus AVR with biological prostheses. METHODS: This is a prospective nonrandomized clinical trial. Each patient underwent a 4D-flow cardiac magnetic resonance scan after surgery, which informed patient-specific computational fluid dynamics models to evaluate WSS at the ascending aortic wall. The adjusted variables were calculated by summing the residuals obtained from a multivariate linear model (with ejection fraction and left ventricle outflow tract-aorta angle as covariates) to the mean of the variables. RESULTS: Ten patients treated with aortic valve neocuspidalization were enrolled and compared with 10 AVR patients. The aortic valve neocuspidalization group showed a significantly lower WSS in the outer curvature segments of the proximal and distal ascending aorta as compared to AVR patients (P = 0.0179 and 0.0412, respectively). WSS levels remained significantly lower along the outer curvature of the proximal aorta in the aortic valve neocuspidalization population, even after adjusting the WSS for the ejection fraction and the left ventricle outflow tract-aorta angle [2.44 Pa (2.17–3.01) vs 1.94 Pa (1.72–2.01), P = 0.02]. CONCLUSIONS: Aortic valve neocuspidalization hemodynamical features are potentially associated with a lower WSS in the ascending aorta as compared to commercially available bioprosthetic valves.
- 17 February 2022
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 114 (6) , 2400
AVNeo, Everyone’s Invited
- 17 February 2022
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 114 (6) , 2400
AVNeo, Everyone’s Invited
- Open Access
- 1 January 2022
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 64 (3)
Is EuroSCORE II still a reliable predictor for cardiac surgery mortality in 2022? A retrospective study study
OBJECTIVES: The European System for Cardiac Operation Risk Evaluation II (EuroSCORE II) is the most common tool used to evaluate the perioperative risk of mortality after cardiac surgery in Europe, and its use is currently recommended by the relevant guidelines. However, recently, its role has been questioned: Several papers have suggested that these algorithms may no longer be adequate for risk prediction due to an overestimation of adult cardiac surgical risk. Our goal was to validate the EuroSCORE II in the prediction of 30-day in-hospital mortality in patients undergoing open cardiac surgery in a high-volume hospital. METHODS: In this retrospective cohort study, we included all patients who underwent cardiac surgery from January 2016 to May 2022 within the departments of cardiac surgery of the Monzino Cardiology Centre in Milan, Italy. We evaluated the discrimination power of the EuroSCORE II by using the receiver operating characteristic curve and the corresponding area under the curve. We performed calibration plots to assess the concordance between the model’s prediction and the observed outcomes. RESULTS: A total of 4,034 patients were included (mean age = 65.1 years; 68% males), of which 674 (16.7%) underwent isolated coronary artery bypass grafting. The EuroSCORE II showed a good discrimination power in predicting 30-day in-hospital mortality (area under the curve = 0.834). However, for interventions performed in an elective setting, very low values of the EuroSCORE II overestimated the observed mortality, whereas for interventions performed in an emergency setting, EuroSCORE II values above 10 extensively underestimated the observed mortality. CONCLUSIONS: Our study suggests that the EuroSCORE II seems not to be a reliable score in estimating the true risk of death, especially in high-risk patients.
- 1 January 2022
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 64 (3)
Open AccessIs EuroSCORE II still a reliable predictor for cardiac surgery mortality in 2022? A retrospective study study
OBJECTIVES: The European System for Cardiac Operation Risk Evaluation II (EuroSCORE II) is the most common tool used to evaluate the perioperative risk of mortality after cardiac surgery in Europe, and its use is currently recommended by the relevant guidelines. However, recently, its role has been questioned: Several papers have suggested that these algorithms may no longer be adequate for risk prediction due to an overestimation of adult cardiac surgical risk. Our goal was to validate the EuroSCORE II in the prediction of 30-day in-hospital mortality in patients undergoing open cardiac surgery in a high-volume hospital. METHODS: In this retrospective cohort study, we included all patients who underwent cardiac surgery from January 2016 to May 2022 within the departments of cardiac surgery of the Monzino Cardiology Centre in Milan, Italy. We evaluated the discrimination power of the EuroSCORE II by using the receiver operating characteristic curve and the corresponding area under the curve. We performed calibration plots to assess the concordance between the model’s prediction and the observed outcomes. RESULTS: A total of 4,034 patients were included (mean age = 65.1 years; 68% males), of which 674 (16.7%) underwent isolated coronary artery bypass grafting. The EuroSCORE II showed a good discrimination power in predicting 30-day in-hospital mortality (area under the curve = 0.834). However, for interventions performed in an elective setting, very low values of the EuroSCORE II overestimated the observed mortality, whereas for interventions performed in an emergency setting, EuroSCORE II values above 10 extensively underestimated the observed mortality. CONCLUSIONS: Our study suggests that the EuroSCORE II seems not to be a reliable score in estimating the true risk of death, especially in high-risk patients.
- Open Access
- 1 January 2022
- Published by Sociedade Brasileira de Cirurgia Cardiovascular in Brazilian Journal of Cardiovascular Surgery
- Vol. 37 (3) , 412-416
A Malignant Lymphoma Growing Inside a Cardiac Mixoma: A Case Report
Lymphomas arising from cardiac myxomas represent a particularly rare pathology, with only few cases reported in the literature. Case presentation: We report a complete excision of a malignant lymphoma arising from a cardiac myxoma in a 44-year-old female patient. The myxoma presented like a floating mass within the left atrium with a maximum diameter of 3.5 cm. The clinical post-operative period was uneventful and the patient was dismissed on the 6th post-operative day. This case reinforces the concept of radical excision of cardiac neoplasms.
- 1 January 2022
- Published by Sociedade Brasileira de Cirurgia Cardiovascular in Brazilian Journal of Cardiovascular Surgery
- Vol. 37 (3) , 412-416
Open AccessA Malignant Lymphoma Growing Inside a Cardiac Mixoma: A Case Report
Lymphomas arising from cardiac myxomas represent a particularly rare pathology, with only few cases reported in the literature. Case presentation: We report a complete excision of a malignant lymphoma arising from a cardiac myxoma in a 44-year-old female patient. The myxoma presented like a floating mass within the left atrium with a maximum diameter of 3.5 cm. The clinical post-operative period was uneventful and the patient was dismissed on the 6th post-operative day. This case reinforces the concept of radical excision of cardiac neoplasms.
- 1 August 2021
- Published by Elsevier in Atherosclerosis
- Vol. 331, e18
Prenylcysteine oxidase 1, A novel player in atherosclerosis
- 1 August 2021
- Published by Elsevier in Atherosclerosis
- Vol. 331, e18
Prenylcysteine oxidase 1, A novel player in atherosclerosis
- Open Access
- 11 March 2021
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 36 (6) , 2095-2098
Percutaneous closure of femoral pseudaneurysm after TAVR
Fully percutaneous transfemoral transcatheter aortic valve replacement (TF‐TAVR) is currently the standard of the catheter‐based treatment of severe aortic stenosis patients. Even though experience, lower delivery catheters profile and improved vascular closure devices performances have resulted in an overall reduction of both vascular and bleeding complications after TAVR, femoral pseudoaneurysm due to incomplete local hemostasis may occur, prolonging the in‐hospital length of stay, causing discomfort to the patient and potentially evolving in serious consequences affecting the outcome. We report two successful percutaneous ultrasound‐guided closure of both the main and secondary femoral access pseudoaneurysm.
- 11 March 2021
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 36 (6) , 2095-2098
Open AccessPercutaneous closure of femoral pseudaneurysm after TAVR
Fully percutaneous transfemoral transcatheter aortic valve replacement (TF‐TAVR) is currently the standard of the catheter‐based treatment of severe aortic stenosis patients. Even though experience, lower delivery catheters profile and improved vascular closure devices performances have resulted in an overall reduction of both vascular and bleeding complications after TAVR, femoral pseudoaneurysm due to incomplete local hemostasis may occur, prolonging the in‐hospital length of stay, causing discomfort to the patient and potentially evolving in serious consequences affecting the outcome. We report two successful percutaneous ultrasound‐guided closure of both the main and secondary femoral access pseudoaneurysm.
- Open Access
- 27 February 2021
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 111 (6) , 1763-1769
Ozaki Procedure: How I Teach It
- 27 February 2021
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 111 (6) , 1763-1769
Open AccessOzaki Procedure: How I Teach It
- Open Access
- 21 November 2020
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 29 (7) , 997-1004
Long-term secondary cardiovascular prevention programme in patients subjected to coronary artery bypass surgery
Aims: Patients with coronary heart disease (CHD) are at very high risk of recurrent events. A strategy to reduce excess risk might be to deliver structured secondary prevention programmes, but their efficacy has been mostly evaluated in the short term and in experimental settings. This is a retrospective case–control study aimed at assessing, in the real world, the efficacy of a secondary prevention programme in reducing long-term coronary event recurrences after coronary artery bypass surgery (CABG). Methods and results: Programme participants (henceforth ‘cases’) were men and women aged <75 years subjected to CABG between 2002 and 2014, living within 100 km of the hospital. Key programme actions included optimization of treatments according to the most updated European preventive guidelines, surveillance of therapy adherence, and customized lifestyle counselling. Controls were analogous patients not involved in the programme because living farther than 100 km away, matched 1:1 with cases for gender, age at CABG, and year of CABG. Both groups (n = 1248) underwent usual periodic cardiology follow-up at our centre. Data on symptomatic or silent CHD recurrences were obtained from the hospital electronic health records. Cox analysis (adjusted for baseline differences between groups) shows that programme participation was associated with a significantly lower incidence throughout 5 years post-CABG of symptomatic [hazard ratio (95% confidence interval): 0.59 (0.38–0.94)] and silent [0.53 (0.31–0.89)] coronary recurrences. Conclusion: In a real-world setting, taking part in a structured longstanding secondary prevention programme, in addition to usual cardiology care, meaningfully lowers the risk of coronary recurrences.
- 21 November 2020
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 29 (7) , 997-1004
Open AccessLong-term secondary cardiovascular prevention programme in patients subjected to coronary artery bypass surgery
Aims: Patients with coronary heart disease (CHD) are at very high risk of recurrent events. A strategy to reduce excess risk might be to deliver structured secondary prevention programmes, but their efficacy has been mostly evaluated in the short term and in experimental settings. This is a retrospective case–control study aimed at assessing, in the real world, the efficacy of a secondary prevention programme in reducing long-term coronary event recurrences after coronary artery bypass surgery (CABG). Methods and results: Programme participants (henceforth ‘cases’) were men and women aged <75 years subjected to CABG between 2002 and 2014, living within 100 km of the hospital. Key programme actions included optimization of treatments according to the most updated European preventive guidelines, surveillance of therapy adherence, and customized lifestyle counselling. Controls were analogous patients not involved in the programme because living farther than 100 km away, matched 1:1 with cases for gender, age at CABG, and year of CABG. Both groups (n = 1248) underwent usual periodic cardiology follow-up at our centre. Data on symptomatic or silent CHD recurrences were obtained from the hospital electronic health records. Cox analysis (adjusted for baseline differences between groups) shows that programme participation was associated with a significantly lower incidence throughout 5 years post-CABG of symptomatic [hazard ratio (95% confidence interval): 0.59 (0.38–0.94)] and silent [0.53 (0.31–0.89)] coronary recurrences. Conclusion: In a real-world setting, taking part in a structured longstanding secondary prevention programme, in addition to usual cardiology care, meaningfully lowers the risk of coronary recurrences.
- 1 March 2018
- Published by Edizioni Minerva Medica in The Journal of Cardiovascular Surgery
- Vol. 59 (2) , 297-299
Lower limb ischemia management in acute Stanford type A aortic dissection
Article: Lower limb ischemia management in acute Stanford type A aortic dissection - The Journal of Cardiovascular Surgery 2018 April;59(2):297-9 - Minerva Medica - Journals
- 1 March 2018
- Published by Edizioni Minerva Medica in The Journal of Cardiovascular Surgery
- Vol. 59 (2) , 297-299
Lower limb ischemia management in acute Stanford type A aortic dissection
Article: Lower limb ischemia management in acute Stanford type A aortic dissection - The Journal of Cardiovascular Surgery 2018 April;59(2):297-9 - Minerva Medica - Journals
- 1 March 2018
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 33 (3) , 133-134
Repair of a pseudoaneurysm following a Yacoub procedure
- 1 March 2018
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 33 (3) , 133-134
Repair of a pseudoaneurysm following a Yacoub procedure